Suvoda Updates Clinical Trial Platform With AI and Unified Access
Suvoda LLC announced in a press release an updated clinical trial platform that combines AI tools, shared data and access to eight products through one login. The Product Launchpad connects RTSM and IRT, eCOA, electronic consent, scheduling, patient payments, travel, site payments, and budgeting and benchmarking.
Suvoda said its agentic RTSM capability has reduced the time from project kickoff to user acceptance testing by up to 80%. Its Sofia assistant lets authorized sponsors and trial sites find information and take permitted actions in multiple languages, while logging each action for auditing and retaining human approval.
A shared data layer transfers participant information between products without repeated entry. The platform also adds finance and travel reporting, digital patient payments, appointment scheduling, questionnaires, ride booking and video calls for remote visits.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 17 AI echo analysis lifts detection of a hard-to-diagnose heart failure type to 78% Nov 17 Astromech acquires Form Bio in $230 million all-stock deal Nov 17 The Rx Assistant launches Builder, a no-code platform for pharma AI experiences Nov 17 Isomorphic Labs raises $5 billion Series C for AI drug design Nov 17 OpenAI says its computer-use agents can handle clinicians' EHR tasks, with CVS Health and Cigna among usersLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
The Rx Assistant launches Builder, a no-code platform for pharma AI experiences
Atlas Bio raises $12.5 million for virtual drug trials
Unio Health Partners deploys Basata's AI agents for patient intake across 60 specialty clinics
Sunlight AI Raises $17.4 Million and Acquires Bradford Medical Associates
Tairex Launches Multi Agent System for Clinical Collaboration
Daily AI Brief: the AI news that matters, in your inbox.